Foreign Investment in the US, and More from CRS
Foreign investment in the United States “dropped sharply in 2012,” according to a newly updated report from the Congressional Research Service, and in 2013 it could fall by another 10%. See Foreign Direct Investment in the United States: An Economic Analysis, December 11, 2013.
Other new and updated CRS reports obtained by Secrecy News include the following.
U.S. Direct Investment Abroad: Trends and Current Issues, December 11, 2013
Campaign Contribution Limits: Selected Questions About McCutcheon and Policy Issues for Congress, December 12, 2013
Patient Protection and Affordable Care Act: Annual Fee on Health Insurers, December 12, 2013
The Paris Club and International Debt Relief, December 11, 2013
Medicaid Coverage of Long-Term Services and Supports, December 5, 2013
Interim Agreement on Iran’s Nuclear Program, December 11, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.